Sibley DR - Search Results

1

Identification of Positive Allosteric Modulators of the D₁ Dopamine Receptor That Act at Diverse Binding Sites.

Luderman KD, Conroy JL, Free RB, Southall N, Ferrer M, Sanchez-Soto M, Moritz AE, Willette BKA, Fyfe TJ, Jain P, Titus S, Hazelwood LA, Aubé J, Lane JR, Frankowski KJ, Sibley DR. Luderman KD, et al. Among authors: sibley dr. Mol Pharmacol. 2018 Oct;94(4):1197-1209. doi: 10.1124/mol.118.113175. Epub 2018 Aug 1. Mol Pharmacol. 2018. PMID: 30068735 Free PMC article.

2

Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.

Barton AC, Black LE, Sibley DR. Barton AC, et al. Among authors: sibley dr. Mol Pharmacol. 1991 May;39(5):650-8. Mol Pharmacol. 1991. PMID: 1674585

3

Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.

Kanterman RY, Mahan LC, Briley EM, Monsma FJ Jr, Sibley DR, Axelrod J, Felder CC. Kanterman RY, et al. Among authors: sibley dr. Mol Pharmacol. 1991 Mar;39(3):364-9. Mol Pharmacol. 1991. PMID: 1848657

4

Cloning and expression of an A1 adenosine receptor from rat brain.

Mahan LC, McVittie LD, Smyk-Randall EM, Nakata H, Monsma FJ Jr, Gerfen CR, Sibley DR. Mahan LC, et al. Among authors: sibley dr. Mol Pharmacol. 1991 Jul;40(1):1-7. Mol Pharmacol. 1991. PMID: 1857334

5

Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells.

Barton AC, Sibley DR. Barton AC, et al. Among authors: sibley dr. Mol Pharmacol. 1990 Oct;38(4):531-41. Mol Pharmacol. 1990. PMID: 1978240

6

Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.

Kreiss DS, Bergstrom DA, Gonzalez AM, Huang KX, Sibley DR, Walters JR. Kreiss DS, et al. Among authors: sibley dr. Eur J Pharmacol. 1995 Apr 24;277(2-3):209-14. doi: 10.1016/0014-2999(95)00069-w. Eur J Pharmacol. 1995. PMID: 7493610

7

Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. Monsma FJ Jr, et al. Among authors: sibley dr. Mol Pharmacol. 1993 Mar;43(3):320-7. Mol Pharmacol. 1993. PMID: 7680751

8

Cyclic AMP-mediated desensitization of D1 dopamine receptor-coupled adenylyl cyclase in NS20Y neuroblastoma cells.

Black LE, Smyk-Randall EM, Sibley DR. Black LE, et al. Among authors: sibley dr. Mol Cell Neurosci. 1994 Dec;5(6):567-75. doi: 10.1006/mcne.1994.1069. Mol Cell Neurosci. 1994. PMID: 7704430

9

The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.

Zhang LJ, Lachowicz JE, Sibley DR. Zhang LJ, et al. Among authors: sibley dr. Mol Pharmacol. 1994 May;45(5):878-89. Mol Pharmacol. 1994. PMID: 7910658

10

D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice.

Friedman E, Jin LQ, Cai GP, Hollon TR, Drago J, Sibley DR, Wang HY. Friedman E, et al. Among authors: sibley dr. Mol Pharmacol. 1997 Jan;51(1):6-11. doi: 10.1124/mol.51.1.6. Mol Pharmacol. 1997. PMID: 9016340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page